Kawasaki Disease

• Immune activation and superantigen hypothesis: The initiating agent is likely an infectious trigger (presumed viral, though specific organism remains undefined) that functions as a superantigen, bypassing normal antigen presentation by directly cross-linking MHC class II molecules on antigen-presenting cells with T-cell receptors. This causes massive clonal expansion of T cells without requirement for conventional antigen processing, leading to polyclonal T-cell activation and excessive production of inflammatory cytokines including IL-1, IL-6, IL-8, TNF-α, and IFN-γ. Toll-like receptor (TLR) signaling, particularly TLR2 and TLR4 pathways, appears crucial in disease initiation through recognition of pathogen-associated molecular patterns.

• Neutrophil-predominant inflammation and arterial involvement: The acute phase (weeks 1-2) is characterized by predominant neutrophilic infiltration of medium-sized arteries, particularly coronary arteries, with the coronary arteritis initially involving the full thickness of the vessel wall. Neutrophils release proteolytic enzymes and reactive oxygen species causing medial necrosis, while neutrophil extracellular traps (NETs) composed of chromatin and granular proteins perpetuate inflammation. This leads to loss of the media layer integrity, aneurysm formation, and weakening of the arterial wall. Systemic inflammation also causes endothelial activation, expression of adhesion molecules (ICAM-1, VCAM-1), and increased vascular permeability.

• Transition to lymphocytic inflammation and fibro-proliferative response: During weeks 2-8, the inflammatory infiltrate shifts toward lymphocytic predominance (CD8+ T cells and macrophages), and a critical fibroproliferative phase begins with myointimal proliferation and neointimal formation within coronary arteries. This can lead to coronary artery luminal narrowing independent of aneurysm formation. The coronary arteritis is panvasculitis affecting intima, media, and adventitia, with subsequent fibrosis and remodeling of the arterial wall. In untreated cases, coronary artery aneurysms develop in 20-30% of children due to destruction of the medial elastic lamina and loss of structural integrity, with giant coronary aneurysms (>8 mm diameter) occurring in 5% of untreated cases.

• Genetic susceptibility factors: Genome-wide association studies (GWAS) have identified multiple genetic loci associated with Kawasaki disease susceptibility, including polymorphisms in genes encoding CD40 ligand, ITPKC (inositol 1,4,5-trisphosphate 3-kinase C), FAM167A-BLK, and other immune-related genes. These genetic variations primarily affect T-cell activation and regulatory T-cell (Treg) function. Reduced Treg numbers and impaired Treg function have been documented during acute Kawasaki disease, allowing unopposed Th1 and Th17 differentiation and expansion of pro-inflammatory effector T cells. HLA associations (particularly HLA-A2, HLA-B44, and HLA-DRB1*0401) vary by ethnicity and appear to influence susceptibility and disease severity.

• Endothelial dysfunction and vasomotor abnormalities: Even after resolution of acute inflammation, Kawasaki disease survivors demonstrate persistent endothelial dysfunction characterized by impaired vasodilation to acetylcholine and abnormal endothelin-1 signaling. Reduced nitric oxide (NO) bioavailability contributes to vasoconstriction and predisposes to thrombosis. Coronary arteries in Kawasaki patients show abnormal flow-mediated dilation and enhanced responsiveness to vasoconstrictive stimuli, perpetuating ischemic risk long-term. These functional abnormalities appear partly mediated by persistent subclinical inflammation and altered autonomic tone.

• Infectious trigger (presumed): Multiple viral and bacterial agents have been proposed as triggers, including paramyxoviruses (measles, mumps), enteroviruses, adenoviruses, parvovirus B19, and coronavirus strains, though no single causative organism has been definitively established. The temporal clustering and seasonal variation in disease incidence (winter and spring peaks in many regions) support an infectious etiology. Recent investigations into SARS-CoV-2 have identified cases of Kawasaki-like disease or multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19, suggesting certain respiratory viruses may trigger disease in predisposed individuals. The infectious agent likely functions as a superantigen rather than requiring conventional antibody responses, explaining the rapid onset and non-specific clinical presentation.

• Genetic susceptibility: Multiple genetic polymorphisms increase disease risk and modify disease severity, with the strongest associations in individuals of East Asian descent, followed by Pacific Islander, Hispanic, and African descent populations, while Caucasian populations show lower incidence. Family clusters and increased risk in siblings suggest heritable predisposition. Children with genetic immunodeficiencies (such as X-linked agammaglobulinemia) show increased Kawasaki disease risk, implicating B-cell dysfunction or inadequate antibody responses in some cases. Male predominance (1.5:1 male-to-female ratio) suggests possible X-linked modifying factors or sexual dimorphism in immune responses.

• Age-related susceptibility: Peak incidence occurs between 1-5 years of age, with rare cases under 6 months (though more common in infants <1 year have increased risk of coronary complications). Children older than 5 years can develop Kawasaki disease but at lower frequency, and the disease is exceptionally rare in adolescents and adults. The age-related incidence pattern suggests that both developmental factors in immune ontogeny and cumulative pathogenic exposures contribute to disease risk.

• Recurrent Kawasaki disease (10% of cases): Some children experience recurrent episodes months to years after initial presentation, suggesting either persistence of the triggering organism or altered immune memory responses that predispose to reactivation with similar stimuli.

• Prolonged fever (mandatory criterion): Fever lasting ≥5 days is a hallmark feature and required for diagnosis. Fever is typically high (39-40°C or higher), spiking, and is notably resistant to acetaminophen and ibuprofen, a characteristic feature that should raise clinical suspicion. The fever persists for 1-2 weeks even with appropriate antibiotic therapy if antibiotics are mistakenly given. Persistent fever despite typical antibiotic courses is a major red flag prompting Kawasaki disease evaluation.

• Oropharyngeal findings: Strawberry tongue (bright red, papillated dorsal tongue surface) is a classic finding but not pathognomonic; occurs in 50-80% of cases. Oral erythema and cracking of lips with potential bleeding occur frequently. Oropharyngeal erythema is diffuse without pharyngeal exudate, helping distinguish from bacterial pharyngitis. Some children develop shallow oral ulcers. The tongue changes are related to villous edema and increased papillae prominence from intense mucosal inflammation.

• Bilateral non-purulent conjunctival injection: Conjunctivitis occurs in 80-90% of cases and is characteristically bilateral, non-exudative (lacking purulent discharge), and painless, distinguishing it from infectious conjunctivitis. Photophobia and anterior uveitis can occur. The conjunctival inflammation reflects systemic vasculitis affecting conjunctival vessels.

• Polymorphous exanthem (≥80% of cases): Rash typically appears within the first 1-2 days of fever and is highly variable in morphology, ranging from maculopapular to scarlatiniform to urticarial patterns. The rash is predominantly truncal and extensor surfaces, frequently sparing palms and soles. Unlike measles or scarlet fever, the rash does not typically involve the face centrally and is usually not pruritic. The exanthem reflects systemic endothelial activation and vasculitis affecting dermal capillaries and small arteries.

• Cervical lymphadenopathy: Unilateral or asymmetric cervical lymphadenopathy occurs in 50-80% of cases, typically involving anterior cervical nodes, usually a single node >1.5 cm. This is the least common criterion and when present with other features, is highly specific for Kawasaki disease. Lymphadenitis represents reactive lymphoid hyperplasia from systemic immune activation.

• Extremity changes: Edema of hands and feet is prominent, with erythema of palms and soles appearing in the first 1-2 weeks. Periungual desquamation of fingers and toes is characteristic but typically appears later (weeks 2-3), with complete shedding of skin in full-thickness layers from fingertips and toes. This distinctive finding occurs in recovery phase and can persist for weeks.

• Lipitis and oral inflammation: Marked erythema and edema of lips is typical, with potential bleeding and crusting. Oral mucosa appears intensely inflamed. This reflects intense inflammation of oral mucous membranes from systemic vasculitis.

• Cardiac findings: Heart murmurs may develop from mitral regurgitation (from papillitis and chordae tendineae involvement) or aortic regurgitation. Cardiogenic shock, congestive heart failure, or acute myocarditis can occur in severe cases with extensive myocardial inflammation. Pericardial friction rub may be heard if pericarditis develops.

• Incomplete/atypical Kawasaki disease: Up to 10-15% of children present with incomplete criteria—lacking one or more principal features (particularly absent rash or limited lymphadenopathy)—but still develop coronary artery disease. These cases are more common in infants <1 year, males, and those presenting very early in disease course. Isolated fever with laboratory evidence of inflammation in a young child at risk warrants echocardiographic evaluation even with incomplete clinical criteria. Atypical presentations may include predominant gastrointestinal symptoms (diarrhea, abdominal pain), hepatitis, or aseptic meningitis.

• Associated systemic manifestations: Hepatomegaly and mild elevation in liver enzymes occur frequently. Diarrhea and abdominal pain reflect intestinal inflammation. Sterile pyuria (>10 WBC/hpf without bacteria) occurs in 50% due to urethritis. Aseptic meningitis with pleocytosis (predominantly lymphocytic) occurs in 25-30%; importantly, CSF findings are typically mild with glucose normal and modest protein elevation. Some children develop hydrops of gallbladder. Arthritis and arthralgia are uncommon but can occur in small/large joints.

• Principal diagnostic criteria (American Heart Association): Diagnosis requires fever ≥5 days PLUS ≥4 of 5 supplemental criteria: (1) bilateral non-purulent conjunctival injection, (2) oropharyngeal changes (strawberry tongue, erythema, cracking lips), (3) polymorphous exanthem, (4) extremity changes (edema, erythema, desquamation), (5) cervical lymphadenopathy (usually unilateral, single node >1.5 cm). Importantly, some children with Kawasaki disease may have only 3 principal criteria (incomplete disease)—recognition of this variant is crucial. Diagnosis can be considered at day 4 of fever if four principal features present.

• Laboratory studies supporting diagnosis: Elevated erythrocyte sedimentation rate (ESR >40 mm/hr, typically 60-100) and C-reactive protein (CRP >3 mg/dL, often 10+ mg/dL) are sensitive but non-specific inflammatory markers. Complete blood count may show leukocytosis (12,000-30,000/μL) with left shift, platelets typically normal early but may exceed 500,000/μL in second-third weeks (thrombocytosis is common by day 10-14 and can be marked). Hemoglobin frequently shows normocytic anemia. Liver function tests may show mild elevations (ALT, AST <100 IU/L typically). Albumin may be decreased. CSF analysis if meningitis suspected shows pleocytosis (usually <100 cells/μL predominantly lymphocytic) with normal glucose and mildly elevated protein.

• Echocardiography: Transthoracic echocardiography is the gold standard for coronary artery assessment and should be performed at baseline (ideally within first 10 days of illness, though can be done up to day 21). Baseline echocardiography assesses: coronary artery diameter (normal <3 mm in children), coronary artery shape and tapering, wall motion abnormalities suggesting myocarditis, ventricular function, mitral regurgitation severity, and pericardial effusion. Coronary arteries should be measured in end-diastole using internal diameter; serial measurements are crucial for comparison. Coronary artery z-scores adjusting for body surface area are used: z-score >2.5 is abnormal, >3.0 is coronary artery ectasia, and >10 indicates giant aneurysm. In patients at high coronary risk, baseline echo at 7-10 days and repeat echo at 4-6 weeks post-illness onset are recommended. Stress testing or advanced imaging (cardiac MRI, CT angiography) may be needed for risk stratification in convalescent phase.

• Acute phase reactants: Markedly elevated procalcitonin and IL-6 correlate with severity and coronary complications. Some centers use scoring systems incorporating laboratory and clinical variables to identify low-risk versus high-risk patients who may benefit from intensified therapy (intravenous immunoglobulin [IVIG] plus corticosteroids). The Egami risk score incorporates male sex, delayed treatment, and certain laboratory findings to predict IVIG resistance.

• Differential diagnosis and distinction from mimics: The primary diagnostic challenge is distinguishing Kawasaki disease from other febrile exanthematous illnesses and sepsis. Measles presents similarly but typically has Koplik spots and cough; MMR vaccination has made this less common. Scarlet fever (Group A Streptococcus) presents with fever, exanthem, and strawberry tongue but has sandpaper-texture rash, responds to antibiotics, and lacks conjunctivitis and extremity edema. Adenovirus infection causes fever and conjunctivitis but exanthem is typically more discrete and cervical adenitis less prominent. Staphylococcal scalded skin syndrome presents with fever and exanthem but involves skin separation and positive Nikolsky sign. Toxic shock syndrome involves hypotension, multiorgan involvement, and often has rash sparing palms/soles. Drug reaction (especially to antibiotics) can mimic Kawasaki disease but timing correlates with medication exposure. Crucial distinction: in Kawasaki disease, children appear relatively well despite fever ("well child who looks sick" is sometimes said because of discordance between fever height and clinical appearance), whereas children with sepsis or other serious bacterial infections appear systemically ill and toxic.

• Intravenous immunoglobulin (IVIG)—first-line therapy: IVIG at 2 g/kg administered as single infusion over 10-12 hours is the cornerstone of acute-phase therapy. IVIG functions through multiple mechanisms:

Cardiac complications (the reason the disease matters)

• Coronary artery aneurysm: destruction of the medial elastic lamina by neutrophilic panvasculitis produces saccular or fusiform dilation, signaled by a z-score >2.5 on serial echocardiography. Giant aneurysms (z ≥10) rarely regress and carry the highest thrombotic risk.
• Coronary thrombosis and myocardial infarction: stagnant flow within an aneurysm plus endothelial dysfunction and reduced nitric oxide bioavailability creates a Virchow-triad milieu. In an infant this presents nonspecifically — inconsolable crying, pallor, vomiting, shock — rather than chest pain. This is an emergency; obtain ECG, troponin, and urgent cardiology input.
• Coronary stenosis/occlusion: myointimal proliferation during the fibroproliferative phase narrows the lumen months to years later, sometimes at the inlet/outlet of a regressed aneurysm, causing exertional ischemia on stress testing.
• Aneurysm rupture: rare, confined largely to giant aneurysms in the first weeks; presents as sudden hemopericardium and tamponade. Emergency.
• Myocarditis, valvulitis, arrhythmia: near-universal subclinical myocarditis may cause depressed function or new mitral regurgitation; conduction disease can produce prolonged PR or ventricular arrhythmia.
• Kawasaki disease shock syndrome: cytokine-driven vasoplegia with hypotension and capillary leak requiring fluids, vasoactive support, and ICU care. Emergency, and a predictor of IVIG resistance and coronary injury.
• Macrophage activation syndrome: suspect with persistent fever, cytopenias, splenomegaly, very high ferritin, and a falling ESR/platelet count. Emergency.

Non-cardiac and treatment-related

• Peripheral artery aneurysms: axillary, brachial, or iliac vessels — "beads on a string" on angiography.
• IVIG effects: aseptic meningitis, infusion reactions, hemolytic anemia from passively transferred anti-A/anti-B isohemagglutinins (falling hemoglobin with positive direct antiglobulin test), and hyperviscosity/thrombosis. Per AAP Red Book, live vaccines (MMR, varicella) are deferred approximately 11 months after high-dose IVIG because passive antibody blunts the response.
• Aspirin effects: Reye syndrome risk with influenza or varicella — the AHA advises annual influenza vaccination for children on long-term aspirin and prompt evaluation for varicella exposure. Gastritis and transaminitis also occur.

• The stem you will see: a toddler (often of East Asian descent) with 5+ days of fever unresponsive to antipyretics and to antibiotics, bilateral non-exudative conjunctivitis, strawberry tongue, cracked lips, a polymorphous rash, swollen red hands and feet, and one big cervical node. Fever ≥5 days plus 4 of 5 criteria makes the diagnosis clinically — no confirmatory test exists.
• Single best next step: obtain an echocardiogram and give IVIG 2 g/kg plus aspirin — do not wait for the echo result to treat. The AHA emphasizes treatment within 10 days of fever onset (ideally by day 7) because that window drives the roughly 5-fold reduction in aneurysm risk.
• Do not withhold IVIG after day 10 if fever persists or if coronary abnormalities/ongoing inflammation (elevated ESR/CRP) are present. Late presentation is not a contraindication.
• The one association examiners test: coronary artery aneurysm — Kawasaki disease is the leading cause of acquired pediatric heart disease in the United States. Giant aneurysm (z ≥10) mandates dual antithrombotic therapy: an antiplatelet agent (aspirin) plus systemic anticoagulation (warfarin or low-molecular-weight heparin).
• Supportive lab clues: sterile pyuria from urethritis, thrombocytosis appearing in week 2 (not week 1), normocytic anemia, transaminitis, hypoalbuminemia, and sterile CSF pleocytosis with normal glucose.
• Timing trap: periungual desquamation is a convalescent finding. A question that offers "wait for peeling to confirm the diagnosis" is offering you a missed treatment window.
• Common distractors: scarlet fever (sandpaper rash, exudative pharyngitis, no conjunctivitis, responds to penicillin), measles (Koplik spots, cough/coryza, cephalocaudal rash), adenovirus (exudative conjunctivitis), and staphylococcal scalded skin (Nikolsky sign).
• Post-IVIG counseling: defer MMR and varicella roughly 11 months (AAP), and give annual influenza vaccine to any child on chronic aspirin because of Reye syndrome risk.